Furthermore, preclinical animal models of PD have demonstrated VNS can improve locomotor control, reduce markers of neuroinflammation, decrease intrasomal alpha synuclein, increase brain derived neurotrophic factor (BDNF) and attenuate neuronal damage within the LC and SN (16, 17). This evidence concerns the gene BDNF and Parkinson disease.